Search research articles
Contact Us
Filters
Showing results (321-330 of 541) with videos related to
Page
of 55
Sort By:
The Journal of Laboratory and Clinical Medicine
|
November 1, 1983
Periportal localization of lorazepam glucuronidation in the isolated perfused rat liver
R A Branch, R Cotham, R Johnson, et al.
Transfusion
|
August 5, 2020
Differential red blood cell age fractionation and Band 3 phosphorylation distinguish two different subtypes of warm autoimmune hemolytic anemia
Evgenia M Bloch, Haley A Branch, Darinka Sakac, et al.
Journal of Investigative Medicine High Impact Case Reports
|
July 11, 2020
Stroke-Onset Seizures During Midbrain Infarction in a Patient With Top of the Basilar Syndrome
Edward C Mader, Vaniolky Losada, Jessica C Baity, et al.
Clinical Pharmacology and Therapeutics
|
August 8, 1998
Selective effect of liver disease on the activities of specific metabolizing enzymes: investigation of cytochromes P450 2C19 and 2D6
A Adedoyin, P A Arns, W O Richards, et al.
Biochemical Pharmacology
|
January 1, 1978
Impaired drug metabolism in experimental cirrhosis in the rat
J P Villeneuve, A J Wood, D G Shand, et al.
Clinical Pharmacology and Therapeutics
|
January 1, 1989
Propranolol's metabolism is determined by both mephenytoin and debrisoquin hydroxylase activities
S A Ward, T Walle, U K Walle, et al.
Plos One
|
March 14, 2012
Circumpolar diversity and geographic differentiation of mtDNA in the critically endangered Antarctic blue whale (Balaenoptera musculus intermedia)
Angela L Sremba, Brittany Hancock-Hanser, Trevor A Branch, et al.
British Journal of Clinical Pharmacology
|
October 1, 1977
Biological determinants of propranolol disposition in normal subjects and patients with cirrhosis [proceedings]
R A Branch, D M Kornhauser, D G Shand, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
April 1, 1982
Assessment of the extent to exogenous prostaglandin I2 is converted to 6-keto-prostaglandin E1 in human subjects
E K Jackson, R P Goodman, G A Fitzgerald, et al.
Clinical Pharmacokinetics
|
November 1, 1978
The influence of cirrhosis on steady-state blood concentrations of unbound propranolol after oral administration
A J Wood, D M Kornhauser, G R Wilkinson, et al.
Page
of 55
Search research articles
Search
Showing results (321-330 of 541) with videos related to
Sort By:
Page
of 55
The Journal of Laboratory and Clinical Medicine
|
November 1, 1983
Periportal localization of lorazepam glucuronidation in the isolated perfused rat liver
R A Branch, R Cotham, R Johnson, et al.
Transfusion
|
August 5, 2020
Differential red blood cell age fractionation and Band 3 phosphorylation distinguish two different subtypes of warm autoimmune hemolytic anemia
Evgenia M Bloch, Haley A Branch, Darinka Sakac, et al.
Journal of Investigative Medicine High Impact Case Reports
|
July 11, 2020
Stroke-Onset Seizures During Midbrain Infarction in a Patient With Top of the Basilar Syndrome
Edward C Mader, Vaniolky Losada, Jessica C Baity, et al.
Clinical Pharmacology and Therapeutics
|
August 8, 1998
Selective effect of liver disease on the activities of specific metabolizing enzymes: investigation of cytochromes P450 2C19 and 2D6
A Adedoyin, P A Arns, W O Richards, et al.
Biochemical Pharmacology
|
January 1, 1978
Impaired drug metabolism in experimental cirrhosis in the rat
J P Villeneuve, A J Wood, D G Shand, et al.
Clinical Pharmacology and Therapeutics
|
January 1, 1989
Propranolol's metabolism is determined by both mephenytoin and debrisoquin hydroxylase activities
S A Ward, T Walle, U K Walle, et al.
Plos One
|
March 14, 2012
Circumpolar diversity and geographic differentiation of mtDNA in the critically endangered Antarctic blue whale (Balaenoptera musculus intermedia)
Angela L Sremba, Brittany Hancock-Hanser, Trevor A Branch, et al.
British Journal of Clinical Pharmacology
|
October 1, 1977
Biological determinants of propranolol disposition in normal subjects and patients with cirrhosis [proceedings]
R A Branch, D M Kornhauser, D G Shand, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
April 1, 1982
Assessment of the extent to exogenous prostaglandin I2 is converted to 6-keto-prostaglandin E1 in human subjects
E K Jackson, R P Goodman, G A Fitzgerald, et al.
Clinical Pharmacokinetics
|
November 1, 1978
The influence of cirrhosis on steady-state blood concentrations of unbound propranolol after oral administration
A J Wood, D M Kornhauser, G R Wilkinson, et al.
Page
of 55